COVID-19 Pandemic: Utilization and Aftermath of Telehealth Services

Panel Session


  • Charles Dunham Shareholder, Greenberg Traurig, LLP
  • Carolyn L. Yocom     Director, Health Care Team, US Government Accountability Office (GOA)



telehealth reimbursement, strategic planning for telehealth companies, optimizing telehealth market success, telehealth regulatory issues, telehealth fraud


Discussion focus on the top legal and regulatory issues affecting the delivery and reimbursement of telehealth services during the COVID-19 pandemic and how legislatures and government agencies at federal and state levels are responding in the aftermath to implement permanent changes and enforce fraudulent activities. The session provides valuable insights for startups and existing telemedicine practices seeking to understand strategic planning to optimize market success and maintain a compliant multi-state practice.


Download data is not yet available.



How to Cite

Dunham, C. ., & Yocom    , C. L. . (2022). COVID-19 Pandemic: Utilization and Aftermath of Telehealth Services: Panel Session. Telehealth and Medicine Today, 7(2).